Template:Endogenous estradiol production rates and plasma estrogen levels
Jump to navigation
Jump to search
Group | E2 (prod) | E2 (levels) | E1 (levels) | Ratio |
---|---|---|---|---|
Pubertal girlsa Tanner stage I (childhood) Tanner stage II (ages 8–12) Tanner stage III (ages 10–13) Tanner stage IV (ages 11–14) Tanner stage V (ages 12–15) Follicular (days 1–14) Luteal (days 15–28) |
? ? ? ? ? ? |
9 (<9–20) pg/mL 15 (<9–30) pg/mL 27 (<9–60) pg/mL 55 (16–85) pg/mL 50 (30–100) pg/mL 130 (70–300) pg/mL |
13 (<9–23) pg/mL 18 (10–37) pg/mL 26 (17–58) pg/mL 36 (23–69) pg/mL 44 (30–89) pg/mL 75 (39–160) pg/mL |
? ? ? ? ? ? |
Prepubertal boys | ? | 2–8 pg/mL | ? | ? |
Premenopausal women Early follicular phase (days 1–4) Mid follicular phase (days 5–9) Late follicular phase (days 10–14) Luteal phase (days 15–28) Oral contraceptive (anovulatory) |
30–100 µg/day 100–160 µg/day 320–640 µg/day 300 µg/day ? |
40–60 pg/mL 60–100 pg/mL 200–400 pg/mL 190 pg/mL 12–50 pg/mL |
40–60 pg/mL ? 170–200 pg/mL 100–150 pg/mL ? |
0.5–1 ? 1–2 1.5 ? |
Postmenopausal women | 18 µg/day | 5–20 pg/mL | 30–70 pg/mL | 0.3–0.8 |
Pregnant women First trimester (weeks 1–12) Second trimester (weeks 13–26) Third trimester (weeks 27–40) |
? ? ? |
1,000–5,000 pg/mL 5,000–15,000 pg/mL 10,000–40,000 pg/mL |
? ? ? |
? ? ? |
Mena | 20–60 µg/day | 27 (20–55) pg/mL | 20–90 pg/mL | 0.4–0.6 |
Footnotes: a = Format is "mean value (range)" or just "range". Sources: [1][2][3][4][5][6][7] |
Template documentation
This template's documentation is missing, inadequate, or does not accurately describe its functionality and/or the parameters in its code. Please help to expand and improve it. (March 2019) |
This template's accessibility is in question. Relevant discussion may be found on the talk page. Information on making articles more accessible can be found at WikiProject Accessibility. |
See also
References
- ↑ Nichols KC, Schenkel L, Benson H (1984). "17 beta-estradiol for postmenopausal estrogen replacement therapy". Obstet Gynecol Surv. 39 (4): 230–45. doi:10.1097/00006254-198404000-00022. PMID 6717863.
- ↑ Cynthia C. Chernecky; Barbara J. Berger (31 October 2012). Laboratory Tests and Diagnostic Procedures – E-Book. Elsevier Health Sciences. pp. 488–. ISBN 1-4557-4502-2.
- ↑ Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC, Place VA (August 1985). "Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement". Am. J. Obstet. Gynecol. 152 (8): 1099–106. doi:10.1016/0002-9378(85)90569-1. PMID 2992279.
- ↑ Kenneth L. Becker (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. pp. 889, 1059–1060, 2153. ISBN 978-0-7817-1750-2.
- ↑ Lalit Bajaj; Stephen Berman (1 January 2011). Berman's Pediatric Decision Making. Elsevier Health Sciences. pp. 160–. ISBN 0-323-05405-6.
- ↑ http://www.ilexmedical.com/files/PDF/Estradiol_ARC.pdf
- ↑ Kuhl H (2003). "Östrogene für den Mann?" [Estrogens for the man?]. Blickpunkt der Mann. 1 (3): 6–12. ISSN 1727-0669.
Editors can experiment in this template's sandbox (create | mirror) and testcases (create) pages. Subpages of this template. |